BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
FXNC
First National Corporation
FXNC has a slight edge over BAC overall, supported by stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FXNC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FXNC's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FXNC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FXNC in the historical PE scenario, which offers more potential upside but is not a forecast.
FXNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $18.45 | -39% |
| Fair | 10x | $24.62 | -19% |
| Forward | 11x | $30.27 | — |
| Current | 13x | $30.27 | — |
| Expensive | 20x | $48.17 | +59% |
Historical ranges are pointers, not guarantees.
FXNC's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FXNC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for FXNC, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FXNC on earnings, with more consistent year-over-year improvement.
FXNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.78 | +16% |
| Q2 2026 | $2.39 | +185% |
| Q1 2026 | $2.32 | +246% |
| Q4 2025 | $1.96 | +96% |
| Q3 2025 | $1.10 | -1.8% |
| Q2 2025 | $0.84 | -33% |
| Q1 2025 | $0.67 | -53% |
| Q4 2024 | $1.00 | -35% |
| Q3 2024 | $1.12 | -54% |
FXNC earned $2.39 per share over the past year, up 185% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FXNC on profitability, with a higher operating margin.
FXNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $24M | +7% |
| Q1 2026 | $22.5M | +6.8% |
| Q4 2025 | $24M | -3.4% |
| Q3 2025 | $22.8M | +52% |
| Q2 2025 | $22.4M | +58% |
| Q1 2025 | $21.1M | +41% |
| Q4 2024 | $24.8M | +79% |
| Q3 2024 | $15M | +8.9% |
FXNC's revenue is growing: $24M last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 30% | +1.5 points |
| Q1 2026 | 27% | +18 points |
| Q4 2025 | 29% | +36 points |
| Q3 2025 | 30% | +11 points |
| Q2 2025 | 28% | +6.2 points |
| Q1 2025 | 9% | -18 points |
| Q4 2024 | -7.6% | +0.9 points |
| Q3 2024 | 19% | -9.4 points |
FXNC's operating margin was 30% last quarter, up 1.5 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FXNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.5M | +58% |
| Q1 2026 | $5.9M | +94% |
| Q4 2025 | $6.9M | +$44.8M |
| Q3 2025 | $6.8M | +38% |
| Q2 2025 | $4.1M | +38% |
| Q1 2025 | $3M | -31% |
| Q4 2024 | -$37.8M | -1071% |
| Q3 2024 | $4.9M | +52% |
FXNC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FXNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FXNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +20.9K shares |
| 1 year | +0.7% | +66.4K shares |
| 3 years | +44% | +2.8M shares |
| 5 years | +86% | +4.2M shares |
| Available history | +82% | +4.1M shares |
FXNC has 9M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2023 | $61,000 |
| Q2 2023 | $482,000 |
| Q1 2023 | $25,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FXNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.5x | Net Cash |
| Q1 2026 | -5.3x | Net Cash |
| Q4 2025 | -5.2x | Net Cash |
| Q3 2025 | -10.6x | Net Cash |
| Q2 2025 | -12.8x | Net Cash |
| Q1 2025 | -22.7x | Net Cash |
| Q4 2024 | -14.2x | Net Cash |
| Q3 2024 | -6.9x | Net Cash |
FXNC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FXNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 52.0 | Neutral |
FXNC's weekly RSI is 54 (neutral) and its Stochastic is 52 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over FXNC on valuation relative to its sector.
FXNC PE vs Financial Services Sector
| Metric | FXNC | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 2.7% below |
| PE % | 71 | 63 | 8 pts above |
FXNC is trading at 13x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FXNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.0 | 1.1% above |
| 20 week MA | $30.5 | 0.6% below |
| 50 week MA | $28.5 | 6.2% above |
| 100 week MA | $25.4 | 19% above |
| 200 week MA | $21.6 | 40% above |
FXNC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FXNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $17.0 | -19% |
| 2021 | $17.0 | $23.0 | +36% |
| 2022 | $23.0 | $17.5 | -24% |
| 2023 | $17.5 | $21.8 | +24% |
| 2024 | $21.8 | $23.8 | +9.3% |
| 2025 | $23.8 | $25.5 | +7.3% |
| 2026 YTD | $25.5 | $30.3 | +19% |
FXNC has the edge over BAC on returns for 2026, with the stronger performance.